Functional human heme oxygenase has a neuroprotective effect on adult rat ganglion cells after pressure-induced ischemia

NeuroReport

Volumn 11, Issue 6, 2000, Pages 1185-1189

  Hegazy, K A ^a   Dunn, M W ^a   Sharma, S C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adenoviral HHO 1; Cell death; Neuroprotection; Recombinant adenovirus; Retinal ganglion cells; Transient ischemia

Indexed keywords

HEME OXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; DRUG MECHANISM; FEMALE; GENE EXPRESSION; ISCHEMIA; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL;

EID: 0034720318     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004270-00008     Document Type: Article

References (48)

1. 1. Quigley HA, Addicks EM, Green WR and Maumenee AE. Arch Ophthalmol 99, 635-649 (1981).
2. 2. Villegas-Pérez MP, Vidal-Sanz M, Bray GH and Aguayo A. J Neurosci 8, 265-280 (1988).
3. 3. Villegas-Pérez MP, Vidal-Sans M, Raminsky M et al. J Neurobiol 24, 23-36 (1993).
4. 4. Berkelaar M, Clark DB, Wang YC et al. J Neurosci 14, 4368-4374 (1994).
5. 5. Peinado-Ramón P, Salvador M, Villegas-Pérez MP and Vidal Sanz M. Invest Ophthalmol Vis Sci 37, 489-500 (1996).
6. 6. García-Valenzuela E, Gorzyca W, Darzynkiewicz Z and Sharma SC. J Neurobiol 25, 431-438 (1994).
7. 7. Quigley HA, Nickells RW, Kerrigan LA et al. Invest Ophthalmol Vis Sci 36, 774-768 (1995).
8. 8. Mansour-Robaey S, Clarke DB, Wang YC et al. Proc Natl Acad Sci USA 91, 1632-1636 (1994).
9. 9. Büchi ER, Suivaizdis I and Fu J. Opthalmologica 203, 138-147 (1991).
10. 10. Büchi ER. Exp Eye Res 53, 573-582 (1991).
11. 11. Hughes WF. Exp Eye Res 53, 573-582 (1991).
12. 12. Szabo ME, Droy-Lefaix MT, Doly M et al. Invest Ophthalmol Vis Sci 32, 1471-1478 (1991).
13. 13. Tkahasi K, Lam TT, Edward DP et al. Arch Ophthalmol 110, 862-870 (1992).
14. 14. Kroll AJ. Arch Ophthalmol 79, 453-469 (1968).
15. 15. Johnson NF and Foulds WS. Exp Eye Res 27, 45-59 (1978).
16. 16. Louzada-Junior P, Dias JJ, Sanots WF et al. J Neurochem 59, 358-363 (1992).
17. 17. Garcia-Valenzuela E, Rayanade R, Perales JC et al. J Neurobiol 32, 111-122 (1994).
18. 18. Abraham NG, Lin JH-C, Schwartzman ML et al. Int J Biochem 20, 543-548 (1987).
19. 19. Dunn MW, Lavrovsky Y, Stoltz RA and Abraham NG. Invest Ophthalmol Vis Sci 36 (Suppl.), 2406 (1995).
20. 20. Abraham NG, Lavrovsky Y, Schwartzman ML et al. Proc Natl Acad Sci USA 92, 6798-67802 (1995).
21. 21. Abraham NG, da Silva J-L, Lavrovsky Y et al. Invest Ophthalmol Vis Sci 36, 2202-2210 (1995).
22. 22. Panahian N, Yoshiura M and Maines MD. J Neurochem 72, 1187-1203 (1999).
23. 23. Maines MD. Annu Rev Pharmacol Toxicol 37, 517-554 (1997).
24. 24. Nishimuera RN, Dwyer BE and Lu S-Y. Neurosci Lett 205, 13-16 (1996).
25. 25. Kutty RK, Kutty G, Wiggert GJ et al. Proc Natl Acad Sci USA 92, 1177-1181 (1995).
26. 26. Willis D, Moore AR, Frederick R and Willoughby DA. Nature Med 2, 87-90 (1996).
27. 27. Stocker P, Yamamoto Y, McDonach AF et al. Science 235, 1043-1047 (1987).
28. 28. Halliwell B and Gutteridge JMC. Methods Enzymol 186, 1-85 (1990).
29. 29. Poss KD and Tonegawa S. Proc Natl Acad Sci USA 94, 10919-10924 (1997).
30. 30. Da Silva J-L, Sharma S, Laquis S et al. Invest Ophthalmol Vis Sci 37(3), 9 (Suppl.), (1996).
31. 31. Perry VH, Henderson Z and Linden R. J Comp Neurol 219, 356-368 (1983).
32. 32. Forester J and Peters A. Nature 214, 245-247 (1967).
33. 33. Chaudhary P, Ahmed F, Quebada P and Sharma SC. Mol Brain Res 67, 36-45 (1999).
34. 34. Cayouette M and Gravel C. Invest Ophthalmol Vis Sci 37, 2022-2028 (1996).
35. 35. Thanos S, Mey J and Thield HJ. J Neurosci 13, 455-466 (1992).
36. 36. Selles-Navarro I, Illegas-Perez MP, Salvador-Silva M et al. Invest Ophthalmol Vis Sci 37, 2002-2014 (1996).
37. 37. Polla BS, Stubbe H, Kantengwa S et al. Inflammation 19, 363-377 (1995).
38. 38. Taketani S, Kohno H, Yoshinaga T and Torkunaga R. FEBS Lett 245, 173-176 (1989).
39. 39. Keyse SM and Tyrrell RM. Proc Natl Acad Sci USA 86, 999-103 (1989).
40. 40. Vercellotti GM et al. Artif Cells Blood Substit Immobil Biotechnol 22, 207-213 (1994).
41. 41. Kadoya C, Domino EF, Yang GY. Stroke 26, 1035-1038 (1995).
42. 42. Balla J, Jacob HS, Balla G et al. Trans Assoc Am Physicians 105, 1-6 (1992).
43. 43. Maltzman W and Czyzyk L. Mol Cell Biol 4, 1689-1694 (1984).
44. 44. Wu H-H and Momand J. 273, 18898-18905 (1998).
45. 45. Nimura T, Weinstein PR, Massa SM et al. Mol Brain Res 37, 201-208 (1996).
46. 46. Dawson TM and Synder SH. Methods Neurosci 31, 62-67 (1996).
47. 47. Hussain AS, Marks GS, Brien JF and Nakatsu K. Can J Physiol Pharmacol 75, 1034-1037 (1997).
48. 48. Durante W, Christoduolides N, Chang K et al. Am J Physiol 273, H317-H323 (1997).